| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.201 | 28.372 | 40.201 | 51.164 | 68.811 |
| Total Income - EUR | - | - | - | - | - | 2.201 | 28.372 | 40.204 | 51.164 | 68.812 |
| Total Expenses - EUR | - | - | - | - | - | 330 | 14.065 | 24.077 | 25.240 | 29.965 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 1.871 | 14.307 | 16.127 | 25.925 | 38.847 |
| Net Profit/Loss - EUR | - | - | - | - | - | 1.805 | 13.878 | 15.733 | 25.423 | 36.927 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Endodiab Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 8.166 | 6.838 | 5.504 |
| Current Assets | - | - | - | - | - | 2.242 | 17.506 | 35.094 | 19.892 | 32.397 |
| Inventories | - | - | - | - | - | 0 | 111 | 112 | 174 | 173 |
| Receivables | - | - | - | - | - | 309 | 3.351 | 10.826 | 13.941 | 23.368 |
| Cash | - | - | - | - | - | 1.933 | 14.044 | 24.157 | 5.777 | 8.857 |
| Shareholders Funds | - | - | - | - | - | 1.846 | 15.684 | 15.774 | 25.464 | 36.967 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 396 | 1.822 | 27.487 | 1.267 | 934 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endodiab Medica S.r.l.